Protandim
 |
| Protandim |
 |
| Protandim-Heath |
Most Related Headlines:
Protandim Supplement Anti-Aging Drug Causes Surge in Stock Price for Parent Company Lifevantage Corporation
LifeVantage to Announce Fiscal Second Quarter 2012 Results on February 14, 2012
Donny Osmond enchants fans with tales of Michael Jackson (video)
LifeVantage Expands Board of Directors and Announces Approval of Tender Offer
Protandim Supplement Anti-Aging Drug Causes Surge in Stock
NIB- Protandim Life Vantage - AntiAging - 30 Day Supply
Protandim safety/helpful - PPMD Community
Protandim Health supplement Anti-Aging Drug Leads to Surge in Share Price for Mother or father Company Lifevantage Company
In less than the usual 30 day time period, the stock price from the Lifevantage Corporation (LFVN) flower by over 19% depending on some changes within management and panel of directors. The stock that currently resides at in regards to a dollar . 5 is still value for money according to analysts in line with the performance of it's primary product, Protandim.
Protandim is really a dietary supplement that has been clinically which may reduce the results of oxidative tension, as well since the progressive rate associated with cellular aging based on the company. Secondary towards the Protandim is LifeVantage TrueScience Anti-Aging Lotion.
LifeVantage, dietary health supplement company which presently holds four patents with regard to Protandim, is reportedly additionally researching and developing products to deal with such issues because altitude sickness, pores and skin cancer, photo aging from the skin, renal failing, osteoarthritis, HIV/AIDS-associated lipodystrophy, pulmonary hypertension, gum disease, heart illness, coronary artery avoid graft failure, asthma, Duchenne muscle dystrophy, metabolic affliction, non-alcoholic fatty lean meats disease, and optic neuropathy.
Lifevantage kept its annual investors meeting on The month of january 10th. The outcomes of the meeting, including adding four brand new board members, seems to be what has sparked the recent improve in stock costs.
According to information released through the company, the new board gathered following the shareholder meeting as well as appointed Woody Spedden since the new Chairman from the Board.
Q2 financial outcomes for LFVN are required to be released following the close on Valentines Day in a few days. Just a couple of months ago the organization increased its 2012 fincal outlook saying it expects revenues associated with $95-$105 million as opposed to previous estimates associated with $80 to $90 zillion. Similarly operating earnings projections were additionally raised by regarding $3-$5 million.
No comments:
Post a Comment